Table 1.
Country | Site | SARS-CoV-2-reported cases (country level) | Plasmodium falciparum infection prevalence in women at delivery* | HIV prevalence in pregnant women |
Mozambique | Manhiça | 228 0001 | 6% | 29%14 |
Gabon | Lambaréné | 48 0001 | 11% | 6%15 |
Libreville | NI | 6%15 |
*Data from 2010 to 2012 in women receiving either two IPTp doses of mefloquine or SP (Tuikue-Ndam et al, unpublished).
IPTp, intermittent preventive treatment in pregnancy; NI, no information; SP, sulfadoxine-pyrimethamine.